Skip to main content
G

Groups

Groups provides rapid Suboxone initiation for opioid use disorder through a hybrid model of in‑person visits and HIPAA‑compliant telehealth, enabling patients to start medication‑assisted treatment within days. The platform includes weekly group therapy, a mobile app for medication reminders and resources, integrated insurance eligibility checks, 24/7 specialist support, and secure cloud‑based data with FHIR APIs for coordinated care.

Burlington, United StatesFounded 2014527
Updated 2 months ago

Funding

$55M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Individuals with opioid use disorder often face long wait times, limited clinic availability, and fragmented support services, which delay access to medication‑assisted treatment (MAT) such as Suboxone. Stigma and complex insurance or Medicaid navigation further reduce treatment uptake, especially for patients in rural or underserved areas.

Solution

Groups delivers rapid, clinically supervised Suboxone initiation through a hybrid model that combines in‑person visits with HIPAA‑compliant telehealth sessions, allowing patients to start treatment within days. A single weekly hour of structured group therapy and peer support is built into the care pathway, reinforcing adherence and relapse prevention. The platform integrates real‑time insurance eligibility checks and Medicaid redetermination assistance, minimizing financial barriers. A dedicated mobile app provides medication reminders, appointment scheduling, and curated recovery resources, keeping patients engaged between visits. 24/7 access to recovery specialists ensures continuous clinical oversight and crisis support. All clinical data are stored in a secure, cloud‑based repository with FHIR‑compatible APIs for seamless EHR integration, enabling coordinated care across providers.

Target Audience

The primary customers are adults diagnosed with opioid use disorder who require medication‑assisted treatment and prefer flexible in‑person or virtual care, particularly those covered by Medicaid or private insurance and residing in regions with limited specialty clinics.

Features

  • HIPAA‑compliant video telehealth platform with electronic prescribing (e‑Rx) for Suboxone
  • Integrated insurance eligibility engine and Medicaid redetermination workflow
  • Weekly 60‑minute group therapy sessions facilitated by certified counselors
  • Mobile application offering medication reminders, resource library, and secure messaging
  • Care coordination services for housing, food, transportation, and employment assistance
  • Real‑time adherence analytics dashboard accessible to clinicians via FHIR API
  • 24/7 recovery specialist hotline for urgent clinical support
  • Secure, role‑based access patient portal with end‑to‑end encryption
This profile is AI-generated and may contain inaccuracies.